4 Meter Gait Speed Test Helpful for Predicting Mortality, Hospitalization Rates in People with IPF

This topic contains 0 replies, has 1 voice, and was last updated by  Pulmonary Fibrosis News Moderator 9 months ago.

  • Author
  • #15736

    Gait speed, measured by the four meter gait speed (4MGS) test, is an independent predictor of all-cause mortality and hospitalization in patients with idiopathic pulmonary fibrosis (IPF), according to a recent study.

    The tool could be used as a prognostic approach to select cohorts in clinical trials, optimize trial endpoints, and identify high-risk patients. Click here to find out more.

    How often do you complete the 4MGS test? How do you feel about your results?

You must be logged in to reply to this topic.

Copyright © 2017-2019 All rights reserved.

©2019 KLEO Template a premium and multipurpose theme from Seventh Queen


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials


Forgot your details?


Create Account